CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies
NCT04605666
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
77
Enrollment
OTHER
Sponsor class
Conditions
B Cell Leukemia
B Cell Lymphoma
Interventions
BIOLOGICAL:
CD19-CAR-T2 Cells
Sponsor
Nanfang Hospital, Southern Medical University